- •Foreword
- •Preface
- •Contents
- •Contributors
- •Introduction
- •Noninfectious Retinal Manifestations
- •Cytomegalovirus Retinitis
- •Necrotizing Herpetic Retinitis (by Varicella Zoster)
- •Toxoplasmic Retinochoroiditis
- •Syphilitic Uveitis, Papillitis, and Retinitis
- •Candida Vitritis and Retinitis
- •Pneumocystis carinii Choroiditis
- •Cryptococcus neoformans Chorioretinitis
- •Mycobacterium Choroiditis
- •B-Cell Lymphoma
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Etiologic Agent
- •Toxocara canis
- •Ancylostoma caninum
- •Baylisascaris procyonis
- •Trematodes
- •Mode of Transmission
- •Diagnosis and Pathogenesis
- •Early Stage
- •Late Stage
- •Ancillary Tests
- •Serologic Test
- •Fluorescein Angiography
- •Visual Field Studies
- •Scanning Laser Ophthalmoscopy (SLO)
- •Optic Coherence Tomography (OCT)
- •GDx® Nerve Fiber Analyzer
- •Differential Diagnosis
- •Management
- •Laser Treatment
- •Oral Treatment
- •Pars Plana Vitrectomy (PPV)
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Epidemiology
- •Etiology and Pathogenesis
- •Systemic Manifestations
- •Clinical Intraocular Manifestations
- •Diagnosis
- •Treatment
- •Surgical Technique
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Pathogenesis and Life Cycle
- •Clinical Manifestations
- •Epidemiology
- •Diagnosis
- •Differential Diagnosis
- •Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Current Epidemiology
- •Eyelid Tuberculosis
- •Conjunctival Tuberculosis
- •Scleral Tuberculosis
- •Phlyctenulosis
- •Corneal Tuberculosis
- •Uveal Tuberculosis
- •Anterior Uveitis
- •Intermediate Uveitis
- •Posterior Uveitis (Choroidal Tuberculosis)
- •Orbital Tuberculosis
- •Retinal Tuberculosis
- •Retinal Vascular Disease
- •Tuberculous Panophthalmitis
- •Neuro-ophthalmological Aspects
- •Ocular Tuberculosis Associated with Mycobacterium bovis
- •Rare Presentations
- •Isolated Macular Edema
- •Isolated Ocular Tuberculosis
- •Intraocular Infection with Pigmented Hypopyon
- •Ocular Tuberculosis After Corticosteroid Therapy
- •Systemic Investigations
- •Ocular Investigations
- •Corticosteroid Therapy
- •Antitubercular Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Pathogenesis
- •Clinical Manifestations
- •Epidemiology
- •Diagnosis
- •Differential Diagnosis
- •Management
- •Pyrimethamine
- •Sulfonamides
- •Folinic Acid
- •Clindamycin
- •Azithromycin
- •Trimethoprim and Sulfamethoxazole
- •Spiramycin
- •Atovaquone
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Bartonellosis
- •Epidemiology
- •Microbiology
- •Clinical Findings in Cat Scratch Disease
- •Systemic Manifestations
- •Ocular Manifestations
- •Parinaud’s Oculoglandular Syndrome (POGS)
- •Retinal and Choroidal Manifestations and Complications
- •Neuroretinitis (Leber’s Neuroretinitis)
- •Multifocal Retinitis and Choroiditis
- •Vasculitis and Vascular Occlusion
- •Peripapillary Bacillary Angiomatosis
- •Uveitis
- •Diagnosis
- •Biopsy and Testing
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •Lyme Disease
- •Diagnosis
- •Ocular Manifestations
- •Intermediate Uveitis
- •Retinal Vasculitis, Branch Retinal Artery, Retinal Vein Occlusion, and Cotton-Wool Spots
- •Neuroretinitis
- •Other Ocular Manifestations
- •Cystoid Macular Edema and Macular Pucker
- •Retinal Pigment Epithelial Detachment
- •Retinitis Pigmentosa-Like Retinopathy
- •Choroidal Neovascular Membrane
- •Acute Posterior Multifocal Placoid Pigment Epitheliopathy-Like Picture
- •Retinal Tear
- •Ciliochoroidal Detachment
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •Syphilis
- •Ocular Manifestations
- •Retina and Choroid
- •Retinal Vasculature
- •Optic Disk
- •Association Between HIV and Syphilis
- •Clinical Importance of Ocular Syphilis
- •Therapy
- •Controversies and Perspectives
- •Clinical Pearls
- •References
- •Introduction
- •Acute Retinal Necrosis
- •Causative Virus
- •Epidemiology
- •Virological Diagnosis
- •Clinical Course
- •Treatment
- •Cytomegalovirus
- •Diagnosis
- •Staging and Progression
- •Laboratory Findings
- •Treatment
- •Pharmacologic
- •Surgical
- •Patient Follow-up
- •Epidemiology
- •Diagnosis
- •HIV Disease
- •HIV Therapy
- •Ocular Manifestations of HIV
- •Progressive Outer Retinal Necrosis
- •Diagnosis
- •Etiology
- •Therapy
- •Rubella
- •West Nile Virus
- •Other Systemic Illnesses
- •Controversies and Perspectives
- •What Is the Best Surgical Approach for Repair of Secondary Retinal Detachment?
- •Focal Points
- •References
- •Introduction
- •Causative Organisms
- •Candidiasis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Aspergillus Retinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Cryptococcal Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Coccidioides immitis Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Histoplasma Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Sporothrix schenckii Chorioretinitis
- •Risk Factors
- •Pathogenesis
- •Clinical Features
- •Diagnosis
- •Treatment
- •Controversies and Perspectives
- •Focal Points
- •References
- •10: Endogenous Endophthalmitis
- •Introduction
- •Clinical Findings
- •Diagnosis
- •How to Culture
- •Polymerase Chain Reaction
- •Treatment
- •Systemic Antibiotics
- •Intravitreous Antibiotics
- •Corticosteroid Therapy
- •Vitrectomy
- •Prognosis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Etiology
- •Genetic Features
- •Immunopathogenesis
- •Diagnosis
- •Posterior Segment Findings
- •Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Epidemiology
- •Prevalence and Incidence
- •Age of Onset
- •The Gender Factor
- •Etiopathogenesis
- •Clinical Features and Diagnosis
- •Ocular Involvement
- •Posterior Segment Involvement
- •Fluorescein Angiography
- •Indocyanine Green Angiography
- •Optical Coherence Tomography
- •Other Ocular Manifestations
- •Complications
- •Histopathology
- •Prognosis of Ocular Disease
- •Juvenile Behçet’s Disease
- •Pregnancy and Behçet’s Disease
- •Differential Diagnosis
- •Management of Ocular Disease
- •Medical Treatment
- •Colchicine
- •Corticosteroids
- •Intravitreal Triamcinolone
- •Cyclosporin A and Tacrolimus (FK506)
- •Anti-tumor Necrosis Factor Treatment
- •Cytotoxic and Other Immunosuppressive Agents
- •Tolerization Therapy
- •Laser Treatment
- •Plasmapheresis
- •Cataract Surgery
- •Trabeculectomy
- •Vitrectomy
- •Controversies and Perspectives
- •Pearls
- •References
- •13: Intraocular Lymphoma
- •Introduction
- •Historical Background
- •Epidemiology
- •Etiology
- •Imaging
- •Diagnosis and Pathology
- •Treatment
- •Controversies and Perspectives
- •Focal Points
- •Acknowledgments
- •References
- •14: Choroidal and Retinal Metastasis
- •Introduction
- •Primary Cancer Sites Leading to Intraocular Metastasis
- •Intraocular Metastasis Onset
- •Choroidal Metastases
- •Ciliary Body Metastases
- •Iris Metastases
- •Retinal Metastases
- •Optic Disk Metastases
- •Vitreous Metastases
- •Ocular Paraneoplastic Syndromes
- •Diagnostic Evaluation for Ocular Metastasis
- •Systemic Evaluation
- •Fluorescein Angiography
- •Indocyanine Green Angiography
- •Ultrasonography
- •Optical Coherence Tomography
- •Computed Tomography
- •Magnetic Resonance Imaging
- •Fine-Needle Aspiration Biopsy
- •Surgical Biopsy
- •Pathology of Ocular Metastasis
- •Observation
- •Radiotherapy
- •Surgical Excision, Enucleation
- •Patient Prognosis
- •Controversies and Perspective
- •Pearls
- •References
- •Introduction
- •CAR Cases
- •CAR Case 1: CAR Secondary to Esthesioneuroblastoma (Olfactory Neuroblastoma)
- •CAR Case 2: CAR Associated with Metastatic Breast Cancer
- •CAR Case 3: Paraneoplastic Optic Neuritis and Retinitis Associated with Small Cell Lung Cancer
- •Paraneoplastic Retinopathy: Melanoma-Associated Retinopathy (MAR)
- •MAR Case
- •Pearls
- •References
- •Introduction
- •Epidemiology
- •Pathophysiology
- •Clinical Presentation
- •Ulcerative Colitis
- •Crohn’s Disease
- •Ocular Manifestations
- •Posterior Segment Lesions
- •Treatment of Ocular Manifestations
- •Whipple’s Disease
- •Diagnosis
- •Extraintestinal Manifestations
- •Central Nervous System
- •Others
- •Treatment
- •Avitaminosis A
- •Pancreatitis
- •Familial Adenomatous Polyposis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Demographics
- •Genetics
- •Fundus Manifestations
- •Management
- •Demographics
- •Genetics
- •Ophthalmologic Features
- •Fundus Manifestations
- •Management
- •Demographics
- •Genetics
- •Fundus Manifestations
- •Management
- •Genetics
- •Ophthalmologic Features
- •Fundus Manifestations
- •Management
- •Genetics
- •Fundus Manifestations
- •Management
- •Genetics
- •Fundus Manifestations
- •Controversies and Perspectives
- •References
- •Pathogenesis and Laboratory Findings
- •Innate Immune System Activation
- •Increased Availability of Self-antigen and Apoptosis
- •Adaptive Immune Response
- •Damage to Target Organs
- •General Clinical Findings
- •Ocular Symptoms
- •Posterior Ocular Manifestations
- •Mild Retinopathy
- •Vaso-occlusive Retinopathy
- •Lupus Choroidopathy
- •Anterior Visual Pathway
- •Posterior Visual Pathway
- •Oculomotor System
- •Anterior Ocular Manifestations
- •Drug-Related Ocular Manifestations
- •General Management
- •Controversies and Perspectives
- •Focal Points
- •References
- •19: Vogt–Koyanagi–Harada Disease
- •Introduction
- •History
- •Epidemiology
- •Immunopathogenesis
- •Histopathology
- •Immunogenetics
- •Clinical Features
- •Extraocular Manifestations
- •Ancillary Test
- •Fluorescein Angiography (FA)
- •Indocyanine Green Angiography (ICGA)
- •Cerebrospinal Fluid Analysis (CSF)
- •Ultrasonography (USG)
- •Ultrasound Biomicroscopy (UBM)
- •Magnetic Resonance Image (MRI)
- •Electrophysiology
- •Differential Diagnosis
- •Sympathetic Ophthalmia
- •Primary Intraocular B-Cell Lymphoma
- •Posterior Scleritis
- •Uveal Effusion Syndrome
- •Sarcoidosis
- •Lyme Disease
- •Treatment
- •Complications
- •Prognosis
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •General
- •Genetics
- •Pathogenesis
- •Ocular Pathology
- •Lens
- •Retina
- •Lens Subluxation
- •Clinical Findings
- •Pathogenesis
- •Differential Diagnosis
- •Treatment
- •Retinal Detachment
- •Clinical Findings
- •Pathogenesis
- •Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •21: Diabetic Retinopathy
- •Introduction
- •Pathogenesis
- •Risk Factors
- •Duration of Disease
- •Glucose Control
- •Blood Pressure Control
- •Lipid Control
- •Other Factors
- •Proliferative Diabetic Retinopathy
- •Advanced Eye Disease
- •Diabetic Macular Edema
- •Management
- •Glycemic Control
- •Blood Pressure Control
- •Serum Lipid Control
- •Aspirin Treatment
- •Laser Photocoagulation
- •Vitrectomy
- •Pharmacotherapy
- •Corticosteroids
- •Triamcinolone Acetonide
- •Fluocinolone Acetonide
- •Extended-Release Dexamethasone
- •Pegaptanib
- •Ranibizumab
- •Bevacizumab
- •Controversies and Perspectives
- •Focal Points
- •References
- •Introduction
- •Hypertensive Retinopathy
- •Hypertensive Choroidopathy
- •Indirect Effects
- •Controversies and Perspectives
- •Summary
- •Focal Points
- •References
- •Introduction
- •Anemia
- •Aplastic Anemia
- •Hemoglobinopathies
- •Sickle Cell Disease
- •Thalassemia
- •Deferoxamine Toxicity
- •Autoimmune Hemolytic Anemia
- •Antiphospholipid Antibody Syndrome
- •Hemophilia and Platelet Disorders
- •Myelodysplastic Disorders
- •Myeloproliferative Disorders
- •Chronic Myelogenous Leukemia
- •Polycythemia Vera
- •Essential Thrombocythemia
- •Leukemias
- •Acute Myeloid Leukemia
- •Lymphoid
- •Lymphomas
- •B Cell Lymphoma
- •Hodgkin’s Lymphoma
- •Plasma Cell Disorders
- •Plasmacytoma/Multiple Myeloma
- •Plasma Cell Leukemia
- •T Cell Lymphomas
- •Controversies/Perspectives
- •Roth Spots
- •Anti-VEGF Therapy
- •Focal Points
- •Anemia
- •Hemoglobinopathies
- •Myelodysplastic Syndrome
- •Myeloproliferative Neoplasms
- •Leukemia
- •Lymphoma
- •References
- •24: The Ocular Ischemic Syndrome
- •Introduction
- •Demography
- •Etiology
- •Symptoms
- •Loss of Vision
- •Amaurosis Fugax
- •Pain
- •Visual Acuity
- •Signs
- •External
- •Anterior Segment Changes
- •Posterior Segment Findings
- •Diagnostic Studies
- •Fluorescein Angiography
- •Electroretinography
- •Carotid Artery Imaging
- •Others
- •Systemic Associations
- •Differential Diagnosis
- •Treatment
- •Systemic Therapy: Carotid Artery
- •Ophthalmic Therapy
- •Controversies and Perspectives
- •Focal Points
- •References
- •25: Ocular Manifestations of Pregnancy
- •Introduction
- •Physiologic Changes
- •Intraocular Pressure
- •Cornea
- •Pathologic Conditions
- •Pregnancy-Induced Hypertension
- •Clinical Features
- •Ocular Manifestations
- •HELLP Syndrome
- •Management of PIH
- •Prognosis
- •Central Serous Retinopathy
- •Occlusive Vascular Disorders
- •Purtscher’s-Like Retinopathy
- •Disseminated Intravascular Coagulation (DIC)
- •Thrombotic Thrombocytopenic Purpura (TTP)
- •Amniotic Fluid Embolism
- •Preexisting Conditions
- •Diabetic Retinopathy
- •Progression
- •Factors Associated with Progression
- •Pathophysiology of Progression
- •Treatment Criteria for Diabetic Retinopathy
- •Follow-up Guidelines
- •Intraocular Tumors
- •Uveal Melanoma
- •Choroidal Osteoma
- •Choroidal Hemangioma
- •Ocular Medications
- •Topical Drops
- •Diagnostic Agents
- •Summary
- •Focal Points
- •References
- •Introduction
- •Toxicity with Diffuse Retinal Changes
- •Toxicity with Pigmentary Degeneration
- •Quinolines
- •Phenothiazines
- •Deferoxamine
- •Toxicity with Crystalline Deposits
- •Tamoxifen
- •Canthaxanthine
- •Toxicity Without Fundus Changes
- •Cardiac Glycosides
- •Phosphodiesterase Inhibitors
- •Toxicity with Retinal Edema
- •Methanol
- •Toxicity with Retinal Vascular Changes
- •Talc
- •Oral Contraceptives
- •Interferon
- •Toxicity with Maculopathy
- •Niacin
- •Sympathomimetics
- •Toxicity with Retinal Folds
- •Sulfanilamide-Like Medications
- •Summary
- •Focal Points
- •References
- •Introduction
- •Diabetes
- •Vascular Disease
- •Hypertensive Retinopathy
- •Hypertensive Optic Neuropathy
- •Thrombotic Microangiopathy
- •Dysregulation of the Alternative Complement Pathway with Renal and Ocular Fundus Changes
- •Papillorenal Syndrome
- •Ciliopathies
- •Senior-Loken Syndrome and Related Syndromes with Nephronophthisis
- •Other Rare Metabolic Diseases
- •Congenital Disorders of Glycosylation (CDG)
- •Cystinosis
- •Fabry Disease
- •Peroxisomal Diseases: Refsum Disease
- •Neoplastic Diseases with Kidney and Ocular Involvement
- •von Hippel-Lindau Disease
- •Light Chain Deposition Disease
- •Controversies and Perspectives
- •Focal Points
- •References
- •Index
9 Retinal and Choroidal Manifestations of Fungal Diseases |
169 |
|
|
Side effects include nausea, vomiting, diarrhea, thrombocytopenia, anemia, leukopenia, hepatotoxicity, and, rarely, bowel perforation.
Fluconazole, miconazole, ketoconazole, and itraconazole are azole derivates. Intraocular penetration is highest for fluconazole and lowest for itraconazole [24]. Fluconazole has excellent oral bioavailability and a relatively long half-life (mean, 25 h) in humans, permitting once-a-day administration. Its clinical toxicity (rigors, fever, vomiting, and renal failure) is less than that of amphotericin B. With its broadspectrum antifungal activity, fluconazole is effective in the treatment of experimental cryptococcal meningitis, systemic and ocular Candida infection, and systemic aspergillosis. The dose of fluconazole for treatment of fungal chorioretinitis without endophthalmitis is 200– 400 mg/day in two divided doses. Several species of Candida other than C. albicans, such as
C. krusei and C. glabrata, as well as Aspergillus and Fusarium species, are known to be resistant to fluconazole. In these cases, itraconazole may be used. Itraconazole has a low toxicity profile and is active against Candida, Aspergillus,
Coccidioides immitis, Cryptococcus neoformans,Histoplasmacapsulatum,andBlastomyces dermatitidis [25]. Available data suggest that none of the azole derivatives are as effective as amphotericin B. Furthermore, antagonism occurs in the anti-Candida effect of amphotericin B and ketoconazole when these two drugs are used in combination. The use of ketoconazole in combination with amphotericin B is not recommended because exposure of C. albicans to ketoconazole may make the organism resistant to amphotericin B [26].
The indications for vitrectomy in patients with fungal chorioretinitis and endophthalmitis are advanced cases with extensive vitreous involvement and poor response to systemic antifungal therapy [27].
Although vitrectomy poses some risks, it does have potential benefits, such as:
•Debulking of inflammatory and infectious material from the vitreous
•Acquisition of a larger sample for laboratory study
•Potential for concentrating the sample by centrifugation or filtration to give a better yield on culture
•An opportunity for intravitreal injection of antifungal agents
•Removal of the scaffolding for vitreoretinal traction bands and epiretinal membranes that can contribute to late-developing macular pucker and retinal detachment
Aspergillus Retinitis
Aspergillus is second in frequency to Candida as a cause of fungal intraocular inflammation. Aspergillus species exists as a saprophytic fungus common in soil and decaying organic matter. Although more than 100 species have been identified, the majority of human illnesses are caused by Aspergillus fumigatus and Aspergillus niger and, less frequently, by Aspergillus flavus and Aspergillus clavatus. Even though exposure to Aspergillus is universal, infection in humans is uncommon. Aspergillus can normally be isolated from the skin and mucous membranes including the conjunctiva. The most common mode of transmission of fungal spores to the human host is via inhalation into the pulmonary alveoli and paranasal sinuses [28]. In the debilitated patient, however, Aspergillus invades and disseminates and may produce lesions in the lung, brain, kidney, gastrointestinal tract, myocardium, liver, spleen, and occasionally the eyes. Reported ocular involvement includes subretinal, serous retinal detachments; choroidal, subretinal, and vitreoretinal granulomas; and abscess formation. Primary anterior segment involvement is rare. Exogenous Aspergillus endophthalmitis can occur following penetrating ocular wounds or ocular surgery.
Risk Factors
•Intravenous drug abuse is the most common risk factor associated with endogenous Aspergillus endophthalmitis (EAE). The organisms enter the bloodstream directly from contaminated drugs, needles, or syringes [29].
170 |
J.F. Arévalo et al. |
|
|
Fig. 9.14 (a) Histopathology of Aspergillus chorioretinitis. (b) Special stains revealed evidence of Aspergillus. (Reprinted with permission from Arévalo JF, Fernández
CF, Mendoza AJ. Chapter 41: Fungal infections. In: Retinal Imaging. Huang D, Kaiser PK, Lowder CY, Traboulsi EI, eds. Philadelphia: Mosby Elsevier: 2006; 366–774)
•Immunosuppression and debilitating diseases, such as [30]:
–Organ transplantation
–Myeloproliferative disorders
–Bronchopulmonary aspergillosis and chronic bronchitis in chi1dren
–Bronchial carcinoid and systemic corticosteroid use
•Prematurity.
•Miliary tuberculosis.
•Alcoholism.
•Goodpasture syndrome.
•Aspergillus endocarditis on prosthetic or natural cardiac valves.
Pathogenesis
Aspergillus has a predilection for invasion of blood vessels producing thrombosis, hemorrhage, infarction, and suppuration (Fig. 9.14). Vascular involvement is the major cause of death. Hematogenous dissemination to the eye can occur following hyphal penetration of blood vessels with an initial choroidal lesion. The infection then spreads to the overlying retina, with progressive abscess formation. Eventually the vitreous is invaded, and finally the anterior segment becomes involved [31]. Septate dichotomously branching hyphae can be found throughout the eye. This also explains the recalcitrance of infection to intravenous amphotericin B, given the absence of patent ocular vessels for drug delivery and the poor intraocular penetration of the drug.
Clinical Features
The ocular presentation and findings are often characteristic and provide possible diagnostic clues. The patients come to the office with rapid onset of pain and severe visual loss. Photophobia, pain, and iridocyclitis may occur, although the anterior segment is often quiet. Some patients present as a marked vitreous haze, a white mass in the vitreous, or a white pupil. The chorioretinal compromise characteristically involves the central macula. A large macular abscess and retinal pseudohypopyon formation are suggestive of the diagnosis (Fig. 9.15). A confluent yellowish macular infiltrate begins in the choroid and subretinal space. The retinal involvement may range from subretinal or subhyaloid infiltrates to fullthickness retinal necrosis (Fig. 9.16). Serous or exudative retinal detachment, intraretinal hemorrhages, choroidal or vitreous abscess, intravitreal granulomata, and posterior scleritis (Fig. 9.17) are also frequent [32].
Diagnosis
Disseminated aspergillosis is often a difficult clinical diagnosis to confirm. High clinical index of suspicion assisted by microbiological and histopathological evaluation helps in arriving at a correct diagnosis, thereby aiding successful treatment. Serologic tests are unreliable whereas blood cultures are usually negative even in fulminant cases. Even in patients with pulmonary involvement, sputum cultures are rarely positive. Invasive culture techniques (e.g., biopsies)
9 Retinal and Choroidal Manifestations of Fungal Diseases |
171 |
|
|
are helpful. Early recognition of intraocular aspergillosis may hasten diagnosis and improve prognosis. Awareness of Aspergillus’ propensity to cause retinal and choroidal infarction may improve the ophthalmologist’s ability to diagnose this visionand life-threatening event.
Fig. 9.15 Man with a history of intravenous drug abuse had vitritis and retinal pseudohypopyon formation due to Aspergillus. (Reprinted with permission from Weishaar PD, Flynn HW Jr, Murray TG, et al. Endogenous Aspergillus endophthalmitis. Clinical features and treatment outcomes. Ophthalmology. 1998;105:57–65)
Intraocular infection with Aspergillus species is difficult to distinguish from the other causes of endophthalmitis on the basis of clinical appearance alone [33]. In addition, Aspergillus species cannot be differentiated, with certainty, from other fungi on histopathological examination.
It has been suggested that a definitive diagnosis of Aspergillus infection is possible only by isolating and identifying the organism after culturing. In culture, all Aspergillus species have septate, dichotomously branching hyphae with conidiophores (stalks) bearing conidia at their ends. They are best identified using periodic acid Schiff or Gomori methenamine silver stain, but may also be seen with Gram stain or hematoxylin and eosin. Aspergillus species rapidly grow on Sabouraud agar and Czapek solution agar. Colonies are initially flat, white, and filamentous but become pigmented within 48 h with the production of conidia (Fig. 9.18).
Anterior chamber aspirates are usually of no value for isolation of the fungus. Despite the presence of hyphae on the surface of the iris, negative anterior chamber aspirates can be reported [34]. Direct examination and culture of vitreous specimens provide a better chance for isolation of the fungus, confirming the role for early vitrectomy in cases of Aspergillus
Fig. 9.16 (a) Yellowish subretinal lesion nasal to the optic disk surrounded by fluid secondary to Aspergillus infection in chronic leukemia. (b) Histology of the fellow enucleated eye confirming Aspergillus infection. (Reprinted
and modified with permission from Machado Od Ode O, Gonçalves R, Fernandes EM, et al. Bilateral Aspergillus endophthalmitis in a patient with chronic lymphocytic leukemia. Br J Ophthalmol. 2003;87:1429–1430)
172 |
J.F. Arévalo et al. |
|
|
Fig. 9.17 (a–b) Fundus photography showing serous retinal detachment with yellowish subretinal lesions secondary to Aspergillus posterior scleritis
Fig. 9.18 (a) Aspergillus fumigatus – columnar head. (b) Aspergillus flavus and Penicillium. (c) Aspergillus niger. (© George L. Barron. Figures reproduced by permission of George L. Barron, Ph.D., D.Sc.)
